 |
|
|
| |
Evolution Of Resistance Associated Variants During Initial Treatment, Viral Failure, And Re-Treatment With Directly Acting Antiviral Therapy
NIH SYNERGY Trial
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Sarah Kattakuzhy1, Eleanor Wilson1, Sreetha Sidharthan2, Mary McLaughlin3, Rachel Silk1, Hongmei
Mo4, Anu Osinusi4, Anita Kohli5, Henry Masur2, Shyam Kottilil1
1Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD; 2Critical Care Medicine Department and 3National
Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; 4Gilead Sciences, Inc., Foster City, CA; 5St.
Joseph's Hospital and Medical Center, Phoenix, AZ
|
| |
|
|
|
|
|
